Ranolazine as a cardioplegia additive improves recovery of diastolic function in isolated rat hearts

Circulation

Volumn 120, Issue SUPPL. 1, 2009, Pages

  Hwang, Hyosook ^a,d   Arcidi Jr , Joseph M ^c,d   Hale, Sharon L ^a,d   Simkhovich, Boris Z ^a,b,d   Belardinelli, Luiz ^b,d   Dhalla, Arvinder K ^b,d   Shryock, John C ^b,d   Kloner, Robert A ^a,b  

^a Heart Institute   (United States)

^b GOOD SAMARITAN HOSPITAL   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d Gilead (Formerly Cardiovascular Therapeutics) Inc   (United States)

Author keywords

Cardiac contractile function; Cardiac contracture; Cardioplegia; Late na + current ranolazine

Indexed keywords

CARDIOPLEGIC AGENT; RANOLAZINE; SODIUM ION; ACETANILIDE DERIVATIVE; PIPERAZINE DERIVATIVE; SODIUM; TETRODOTOXIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; FEMALE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE CONTRACTURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM CURRENT; ANGINA PECTORIS; ANIMAL; DIASTOLE; DRUG EFFECT; HEART ARREST; HEART CONTRACTION; METABOLISM; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ACETANILIDES; ANGINA PECTORIS; ANIMALS; DIASTOLE; FEMALE; HEART ARREST, INDUCED; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; SODIUM; TETRODOTOXIN;

EID: 70349786605     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.844167     Document Type: Article

References (25)

1. 1. Sett SS, Tearle H, LeBlanc JG. Effect of glutamate-aspartate reperfusion, on postischemic neonatal myocardium. J Thorac Cardiovasc Surg. 1997; 113:462-466. (Pubitemid 27149129)
2. Rosenkranz ER, Buckberg GD, Laks H, Mulder DG. Warm, induction of cardioplegia with glutamate-enriched blood in coronary patients with, cardiogenic shock who are dependent on. inotropic drugs and intra-aortic balloon support. J Thorac Cardiovasc Surg. 1983;86:507-518.
3. 3. The IONA study group. Effect of nicorandil on coronary events in. patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet. 2002;359:1269-1275. (Pubitemid 34310631)
4. 4. Greenwood JP, Malik I, Jennings P, Stevenson RN. Haemodynamic and electrocardiographic consequences of severe nicorandil toxicity. Emerg Med J. 2003;20:98-100. (Pubitemid 36163548)
5. Hale SL, Shryock JC, Belardinelli L, Sweeney M, Kloner RA. Late sodium current inhibition as a new cardioprotective approach. J Mol Cell Cardiol. 2008;44:954-967.
6. 6. Ver Donck L, Borgers M, Verdonck F. Inhibition of sodium and calcium overload pathology in the myocardium: a new cytoprotective principle. Cardiovasc Res. 1993;27:349-357. (Pubitemid 23116131)
7. 7. Murphy E, Cross H, Steenbergen C. Sodium, regulation during ischemia versus reperfusion, and its role in injury. Circ Res. 1999;84:1469-1470. (Pubitemid 29293226)
8. 8. Imahashi K, Kusuoka H, Hashimoto K, Yoshioka J, Yamaguchi H, Nishimura T. Intracellular sodium accumulation during ischemia as the substrate for reperfusion injury. Circ Res. 1999;84:1401-1406. (Pubitemid 29293218)
9. 9. Fraser H, Belardinelli L, Wang L, Light PE, McVeigh JJ, Clanachan AS. Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts. J Mol Cell Cardiol. 2006;41:1031-1038. (Pubitemid 44791334)
10. 10. Song Y, Shryock JC, Wagner S, Maier LS, Belardinelli L. Blocking late sodium current reduces hydrogen, peroxide-induced arrhythmogenic activity and contractile dysfunction. J Pharmacol Exp Ther. 2006;318: 214-222. (Pubitemid 43920758)
11. 11. Song Y, Shryock JC, Wu L, Belardinelli L. Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes. J Cardiovasc Pharmacol. 2004;44:192-199. (Pubitemid 38982162)
12. 12. Haigney MC, Lakatta EG, Stem MD, Silverman HS. Sodium, channel blockade reduces hypoxic sodium loading and sodium-dependent calcium, loading. Circulation, 1994;90:391-399. (Pubitemid 24979897)
13. 13. Chairman BR, Pepine CJ, Parker JO, Skopal J, Chumakova G, Kuch J, Wang W, Skettino SL, Wolff AA. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. JAMA. 2004;291:309-316. (Pubitemid 38101603)
14. 14. Chairman BR, Skettino SL, Parker JO, Hanley P, Meluzin J, Kuch J, Pepine CJ, Wang W, Nelson JJ, Hebert DA, Wolff AA. Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. J Am Coll. Cardiol. 2004;43:1375-1382. (Pubitemid 38496341)
15. 15. Antzelevitch C, Belardinelli L, Zygmunt AC, Burashnikov A, Di Diego JM, Fish JM, Cordeiro JM, Thomas G. Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties. Circulation. 2004;110:904-910. (Pubitemid 39136212)
16. 16. Wang P, Fraser H, Lloyd SG, McVeigh JJ, Belardinelli L, Chatham JC. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid, oxidation., on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion. J Pharmacol. Exp Ther. 2007;321:213-220. (Pubitemid 46456960)
17. Undrovinas AI, Fleidervish IA, Makielski JC. Inward sodium current at resting potentials in single cardiac myocytes induced by the ischemic metabolite lysophosphatidylcholine. Circ Res. 1992;71:1231-1241.
18. Hwang H, Arcidi JMJ, Hale SL, Simkhovich BZ, Belardinelli L, Dhalla AK, Shryock JC, Kloner RA. Ranolazine as an adjunct to cardioplegia: A potential new therapeutic application. J Cardiovasc Pharmacol Ther. 2009;14:125-133.
19. 19. Schram. G, Zhang L, Derakhchan K, Ehrlich. JR, Belardinelli L, Nattel S. Ranolazine: ion-channel-blocking actions and in vivo electrophysiological effects. Br J Pharmacol. 2004;142:1300-1308. (Pubitemid 39185852)
20. 20. Rao V, Borger MA, Weisel RD, Ivanov J, Christakis GT, Cohen G, Yau TM. Insulin cardioplegia for elective coronary bypass surgery. J Thorac Cardiovasc. Surg. 2000;119:1176-1184. (Pubitemid 30412615)
21. Rao V, Christakis GT, Weisel RD, Ivanov J, Borger MA, Cohen. G. The insulin cardioplegia trial: myocardial protection for urgent coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2002;123: 928-935.
22. 22. Rao PS, Brock FE, Cleary K, Mueller H, Bamer HB. Effect of intraoperative propranolol on serum creatine kinase MB release in patients having elective cardiac operations. J Thorac Cardiovasc Surg. 1984;88: 562-566. (Pubitemid 14013951)
23. 23. Hachida M, Lu H, Ohkado A, Gu H, Zhang XL, Furukawa H, Nakanishi T, Koyanagi H. Effect of ATP-potassium channel opener nicorandil on. long-term cardiac preservation. J Cardiovasc Surg (Torino). 2000;41: 533-539. (Pubitemid 30756805)
24. + regulation in cardiac myocytes. Cardiovasc Res. 2003;57:897-912.
25. Bers DM. Calcium fluxes involved in control of cardiac myocyte contraction. Circ Res. 2000;87:275-281.